<DOC>
	<DOCNO>NCT01289249</DOCNO>
	<brief_summary>The object study investigate whether included patient receive treatment effective bacteria define sensitive meropenem current treatment regimen . Will investigators finding motivate routine monitoring plasma concentration child receive meropenem ? Up 50 patient include study , participant child .</brief_summary>
	<brief_title>Meropenem Plasma Concentration Measurements Pediatric Medical Ward , Oslo University Hospital , Rikshospitalet</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>Children age 3 month 18 year receive treatment meropenem . Inclusion independent long patient receive treatment . Children receive treatment ( except hemodialysis ) /other medication include . Children le three month age . Patients receive hemodialysis . Lack consent .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>meropenem</keyword>
	<keyword>child</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>treatment evaluation</keyword>
</DOC>